two U.S. health agencies plan to study the effects of ADHD drugs on the heart. Take a look:Reuters is reporting that
The U.S. Food and Drug Administration said it will collaborate with the Agency for Healthcare Research and Quality to examine clinical data of about 500,000 children and adults who have taken ADHD drugs, which include Novartis AG's Ritalin and Shire Plc's Adderall.For more on ADHD, take a look at this post from the other day: Ritalin Stunts.
The analysis, expected to take about two years, will include all drugs currently marketed for treating ADHD. Millions of people take the medicines.
Because the drugs can increase heart rate and blood pressure, there are concerns they may raise the risk of heart attacks, strokes or other cardiovascular problems.